Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -16.26x is in line with its 1-year average of -15.94x, around the middle of its 1-year range (-20.44x–-12.34x).
0.25% below its 12-month average of -16.22x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -12.34x.
INTEREST COVERAGE RATIO
-16.26x
INTEREST COVERAGE RATIO AVG TTM
-16.22x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-0.25%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.63x
median of 452 covered companies
CURRENT VS SECTOR MEDIAN
-188.55%
vs the sector median at left
CalciMedica, Inc.
Market Cap
$4.75M
Interest Coverage Ratio
-16.26x
TTM Avg
-16.22x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.79M
Interest Coverage Ratio
N/A
TTM Avg
1.10x
3Y Avg
1.10x
5Y Avg
1.10x
Market Cap
$4.64M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.50M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.45M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.34M
Interest Coverage Ratio
-765.53x
TTM Avg
1.76x
3Y Avg
1.76x
5Y Avg
1.76x
Market Cap
$5.17M
Interest Coverage Ratio
-13.75x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.20M
Interest Coverage Ratio
-10.70x
TTM Avg
10.43x
3Y Avg
9.52x
5Y Avg
9.52x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CalciMedica, Inc. (CALC) | $4.75M | -16.26x | -16.22x | N/A | N/A |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.79M | N/A | 1.10x | 1.10x | 1.10x |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.64M | N/A | N/A | N/A | N/A |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.50M | N/A | N/A | N/A | N/A |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.45M | N/A | N/A | N/A | N/A |
| Imunon, Inc. (IMNN)vs › | $5.08M | N/A | 1.00x | 1.02x | 1.02x |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.34M | -765.53x | 1.76x | 1.76x | 1.76x |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.17M | -13.75x | N/A | N/A | N/A |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.20M | -10.70x | 10.43x | 9.52x | 9.52x |
| Lunai Bioworks Inc. (LNAI)vs › | $5.21M | -25.56x | N/A | N/A | N/A |
Interest Coverage
-16.3x
Debt/Equity
0.00
Current Ratio
5.58
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -12.34x |
| 2026-03-31 | -17.59x |
| 2025-12-31 | -13.49x |
| 2025-09-30 | -17.23x |
| 2025-06-30 | -20.44x |
| 2025-03-31 | -14.53x |
